drugset / Trial / NCT02650596

Effects of GLP-1 on Chronic Heart Failure

NCT02650596

Unknown 68 enrolled Shi Yang
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators planned to evaluate the effects of liraglutide on left ventricular function in chronic heart failure patients with type 2 diabetes.

Timeline

Start
2016-01
Primary completion
2018-02
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 1.8 mg Subcutaneous

Indications